Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jai Rautela

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Current Opinion in Immunology|November 12, 2016
IL-15 signaling in NK cell cancer immunotherapyJai Rautela, Nicholas D Huntington
Journal of Leukocyte Biology|January 19, 2021
Drug target validation in primary human natural killer cells using CRISPR RNPJai Rautela, Elliot Surgenor, Nicholas D Huntington
Nature Reviews. Cancer|June 26, 2020
The cancer-natural killer cell immunity cycleNicholas D Huntington, Joseph Cursons, Jai Rautela
Cancer Research|September 25, 2013
The emerging role of immunosurveillance in dictating metastatic spread in breast cancerClare Y Slaney, Jai Rautela, Belinda S Parker
Nature Reviews. Cancer|February 26, 2016
Antitumour actions of interferons: implications for cancer therapyBelinda S Parker, Jai Rautela, Paul J Hertzog
Cellular & Molecular Immunology|May 23, 2025
Adjusting the scope of natural killer cells in cancer therapyZihen Shen, Xiangpeng Meng, Jai Rautela, et al.
Journal of Leukocyte Biology|May 13, 2019
Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditionsRobert J Hennessy, Kim Pham, Rebecca Delconte, et al.
Immunology and Cell Biology|March 27, 2018
Molecular insight into targeting the NK cell immune response to cancerJai Rautela, Fernando Souza-Fonseca-Guimaraes, Soroor Hediyeh-Zadeh, et al.
Frontiers in Immunology|December 31, 2024
Soluble CD52 mediates immune suppression by human seminal fluidLeonard C Harrison, Natalie L Stone, Esther Bandala-Sanchez, et al.
Frontiers in Immunology|May 24, 2019
Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF-βLachlan P Healy, Gustavo R Rossi, Jai Rautela, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Current Opinion in Immunology|November 12, 2016
IL-15 signaling in NK cell cancer immunotherapyJai Rautela, Nicholas D Huntington
Journal of Leukocyte Biology|January 19, 2021
Drug target validation in primary human natural killer cells using CRISPR RNPJai Rautela, Elliot Surgenor, Nicholas D Huntington
Nature Reviews. Cancer|June 26, 2020
The cancer-natural killer cell immunity cycleNicholas D Huntington, Joseph Cursons, Jai Rautela
Cancer Research|September 25, 2013
The emerging role of immunosurveillance in dictating metastatic spread in breast cancerClare Y Slaney, Jai Rautela, Belinda S Parker
Nature Reviews. Cancer|February 26, 2016
Antitumour actions of interferons: implications for cancer therapyBelinda S Parker, Jai Rautela, Paul J Hertzog
Cellular & Molecular Immunology|May 23, 2025
Adjusting the scope of natural killer cells in cancer therapyZihen Shen, Xiangpeng Meng, Jai Rautela, et al.
Journal of Leukocyte Biology|May 13, 2019
Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditionsRobert J Hennessy, Kim Pham, Rebecca Delconte, et al.
Immunology and Cell Biology|March 27, 2018
Molecular insight into targeting the NK cell immune response to cancerJai Rautela, Fernando Souza-Fonseca-Guimaraes, Soroor Hediyeh-Zadeh, et al.
Frontiers in Immunology|December 31, 2024
Soluble CD52 mediates immune suppression by human seminal fluidLeonard C Harrison, Natalie L Stone, Esther Bandala-Sanchez, et al.
Frontiers in Immunology|May 24, 2019
Loss-of-Function in SMAD4 Might Not Be Critical for Human Natural Killer Cell Responsiveness to TGF-βLachlan P Healy, Gustavo R Rossi, Jai Rautela, et al.
Pageof 5